[Considerations on the use of cytostatic preparations in rheumatoid arthritis in children].
D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use* / Q000633:toxicity; D001171:Arthritis, Juvenile / Q000150:complications / Q000188:drug therapy*; D002648:Child; D004359:Drug Therapy, Combination; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D013997:Time Factors
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D007166:Immunosuppressive Agents
Nekotorye soobrazheniia o primenenii tsitostaticheskikh preparatov pri revmatoidnom artrite u deteĭ.